A walk in the PARC: developing and implementing 21st century chemical risk assessment in Europe.

Chemicals Exposure assessment Hazard characterisation Human biomonitoring (HBM) New approach methods (NAM) Next-generation risk assessment (NGRA) Safety assessment

Journal

Archives of toxicology
ISSN: 1432-0738
Titre abrégé: Arch Toxicol
Pays: Germany
ID NLM: 0417615

Informations de publication

Date de publication:
03 2023
Historique:
received: 08 12 2022
accepted: 14 12 2022
pubmed: 17 1 2023
medline: 3 3 2023
entrez: 16 1 2023
Statut: ppublish

Résumé

Current approaches for the assessment of environmental and human health risks due to exposure to chemical substances have served their purpose reasonably well. Nevertheless, the systems in place for different uses of chemicals are faced with various challenges, ranging from a growing number of chemicals to changes in the types of chemicals and materials produced. This has triggered global awareness of the need for a paradigm shift, which in turn has led to the publication of new concepts for chemical risk assessment and explorations of how to translate these concepts into pragmatic approaches. As a result, next-generation risk assessment (NGRA) is generally seen as the way forward. However, incorporating new scientific insights and innovative approaches into hazard and exposure assessments in such a way that regulatory needs are adequately met has appeared to be challenging. The European Partnership for the Assessment of Risks from Chemicals (PARC) has been designed to address various challenges associated with innovating chemical risk assessment. Its overall goal is to consolidate and strengthen the European research and innovation capacity for chemical risk assessment to protect human health and the environment. With around 200 participating organisations from all over Europe, including three European agencies, and a total budget of over 400 million euro, PARC is one of the largest projects of its kind. It has a duration of seven years and is coordinated by ANSES, the French Agency for Food, Environmental and Occupational Health & Safety.

Identifiants

pubmed: 36645448
doi: 10.1007/s00204-022-03435-7
pii: 10.1007/s00204-022-03435-7
pmc: PMC9968685
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

893-908

Subventions

Organisme : European Commission
ID : 101057014

Informations de copyright

© 2023. The Author(s).

Références

Arch Toxicol. 2020 Oct;94(10):3581-3592
pubmed: 32886186
Crit Rev Toxicol. 2014 Aug;44 Suppl 3:6-16
pubmed: 25070414
Environ Int. 2021 Jan;146:106257
pubmed: 33395925
Curr Opin Toxicol. 2018 Jun 01;9:1-7
pubmed: 29682628
Environ Health Perspect. 2015 Mar;123(3):255-63
pubmed: 25493439
Int J Hyg Environ Health. 2017 Mar;220(2 Pt A):94-97
pubmed: 28284775
Int J Hyg Environ Health. 2020 Sep;230:113622
pubmed: 33045523
Crit Rev Toxicol. 2018 Oct;48(9):796-814
pubmed: 30632445
Int J Hyg Environ Health. 2021 Aug;237:113809
pubmed: 34455198
ALTEX. 2015;32(1):9-24
pubmed: 25372315
Int J Hyg Environ Health. 2023 Jan;247:114072
pubmed: 36395655
Front Toxicol. 2022 Sep 19;4:933197
pubmed: 36199824
Crit Rev Toxicol. 2014 Aug;44 Suppl 3:1-5
pubmed: 25070413
Int J Hyg Environ Health. 2021 May;234:113740
pubmed: 33774419
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
Environ Int. 2020 Jun;139:105545
pubmed: 32361063
Arch Toxicol. 2019 Dec;93(12):3643-3667
pubmed: 31781791
Arch Toxicol. 2020 Jul;94(7):2435-2461
pubmed: 32632539
Int J Hyg Environ Health. 2012 Feb;215(2):172-5
pubmed: 21940209
J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):51-138
pubmed: 20574894
Arch Toxicol. 2015 Jan;89(1):15-23
pubmed: 25433540
Sci Total Environ. 2021 Nov 15;795:148776
pubmed: 34328937

Auteurs

P Marx-Stoelting (P)

German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany. philip.marx-stoelting@bfr.bund.de.

G Rivière (G)

French Agency for Food, Environmental and Occupational Health and Safety (ANSES), 94701, Maisons-Alfort, France.

M Luijten (M)

National Institute for Health and Environment (RIVM), Bilthoven, The Netherlands.

K Aiello-Holden (K)

German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany.

N Bandow (N)

German Environment Agency (UBA), Wörlitzer Platz 1, 06844, Dessau, Germany.

K Baken (K)

VITO (Flemish Institute for Technological Research), Boeretang 200, 2400, Mol, Belgium.

A Cañas (A)

National Centre for Environmental Health, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

A Castano (A)

National Centre for Environmental Health, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

S Denys (S)

Santé Publique France (SpFrance), 12, Rue du Val D'Osne, 94415, St. Maurice, France.

C Fillol (C)

Santé Publique France (SpFrance), 12, Rue du Val D'Osne, 94415, St. Maurice, France.

M Herzler (M)

German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany.

I Iavicoli (I)

Department of Public Health, University of Naples Federico II (UNINA), Naples, Italy.

S Karakitsios (S)

Aristoteles University Thessaloniki (AUTH), Thessaloniki, Greece.

J Klanova (J)

Masaryk Uinversity, Recetox, Kotlarska 2, 61137, Brno, Czechia.

M Kolossa-Gehring (M)

German Environment Agency (UBA), Wörlitzer Platz 1, 06844, Dessau, Germany.

A Koutsodimou (A)

General Chemical State Laboratory of Greece, Athens, Greece.

J Lobo Vicente (JL)

European Environment Agency, Kongens Nytorv 6, 1050, Copenhagen K, Denmark.

I Lynch (I)

School of Geography, Earth and Environmental Sciences, University of Birmingham (UoB), Edgbaston, Birmingham, B15 2TT, UK.

S Namorado (S)

National Institute of Health Dr. Ricardo Jorge (INSA), Avenida Padre Cruz, 1649-016, Lisbon, Portugal.

S Norager (S)

European Commission, DG Research and Innovation, Orban 09/199, 1049, Brussels, Belgium.

A Pittman (A)

French Agency for Food, Environmental and Occupational Health and Safety (ANSES), 94701, Maisons-Alfort, France.

S Rotter (S)

German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany.

D Sarigiannis (D)

Aristoteles University Thessaloniki (AUTH), Thessaloniki, Greece.

M J Silva (MJ)

National Institute of Health Dr. Ricardo Jorge (INSA), Avenida Padre Cruz, 1649-016, Lisbon, Portugal.

J Theunis (J)

VITO (Flemish Institute for Technological Research), Boeretang 200, 2400, Mol, Belgium.

T Tralau (T)

German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany.

M Uhl (M)

Austrian Federal Environments Agency, Vienna, Austria.

J van Klaveren (J)

National Institute for Health and Environment (RIVM), Bilthoven, The Netherlands.

L Wendt-Rasch (L)

Swedish Chemicals Agency (KemI), Vasagatan 12D, 172 67, Sundbyberg, Sweden.

E Westerholm (E)

Swedish Chemicals Agency (KemI), Vasagatan 12D, 172 67, Sundbyberg, Sweden.

C Rousselle (C)

French Agency for Food, Environmental and Occupational Health and Safety (ANSES), 94701, Maisons-Alfort, France.

P Sanders (P)

French Agency for Food, Environmental and Occupational Health and Safety (ANSES), 94701, Maisons-Alfort, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH